COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1176: Articles 11751-11760  | Next

Whole-genome sequencing of Vero E6 (C1008) and comparative analysis of four Vero cell sublines
Konishi, K., Yamaji, T., Sakuma, C., Kasai, F., Endo, T., Kohara, A., Hanada, K., Osada, N.
10.1101/2021.10.26.466002 — Posted: 2021-10-29
A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity
Gomez-Carballa, A., Rivero-Calle, I., Pardo-Seco, J., Gomez-Rial, J., Rivero-Velasco, C., Rodriguez-Nunez, N., Barbeito-Castineiras, G., Perez-Freixo, H., Cebey-Lopez, M., Barral-Arca, R., Rodriguez-Tenreiro, C., Dacosta-Urbieta, A., Bello, X., Pischedda, S., Curras-Tuala, M. J., Viz-Lasheras, S., Martinon-Torres, F., Salas, A., GEN-COVID
10.1101/2021.10.27.466206 — Posted: 2021-10-29
An iTSC-derived placental model of SARS-CoV-2 infection unveils ACE2-dependent susceptibility in syncytiotrophoblasts
Chen, J., Neil, J. A., Tan, J. P., Rudraraju, R., Mohenska, M., Sun, Y. B., Sun, G., Zhou, Y., Li, Y., Drew, D., Pymm, P., Tham, W.-H., Rossello, F. J., Nie, G., Liu, X., Subbarao, K., Polo, J. M.
10.1101/2021.10.27.465224 — Posted: 2021-10-29
Risk factors for severe PCR-positive SARS-CoV-2 infection in hospitalized children: a multicenter cohort study
Schober, T., Caya, C., Barton, M., Bayliss, A., Bitnun, A., Bowes, J., Brenes-Chacon, H., Bullard, J., Cooke, S., Dewan, T., Dwilow, R., El Tal, T., Foo, C., Gill, P., Haghighi Aski, B., Kakkar, F., Lautermilch, J., Laxer, R. M., Lefebvre, M.-A., Leifso, K., Le Saux, N., Lopez, A., Manafi, A., Morris, S. K., Nateghian, A., Panetta, L., Petel, D., Piche, D., Purewal, R., Restivo, L., Roberts, A., Sadarangani, M., Scuccimarri, R., Soriano-Fallas, A., Tehseen, S., Top, K. A., Ulloa-Gutierrez, R., Viel-Theriaul, I., Wong, J. K., Yea, C., Yeh, A., Yock-Corrales, A., Robinson, J., Papenburg, J.
10.1101/2021.10.28.21265616 — Posted: 2021-10-29
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults >= 65 years of age: a Phase II, open-label study
Izikson, R., Brune, D., Bolduc, J.-S., Bourron, P., Fournier, M., Mallett Moore, T., Pandey, A., Perez, L., Sater, N., Shrestha, A., Wague, S., Samson, S. I.
10.1101/2021.10.29.21265248 — Posted: 2021-10-29
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine
Mayfield, H. J., Lau, C. L., Sinclair, J. E., Brown, S. J., Baird, A., Litt, J., Vuorinen, A., Short, K. R., Waller, M., Mengersen, K.
10.1101/2021.10.28.21265588 — Posted: 2021-10-29
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
De Winter, F. H., Hotterbeekx, A., Huizing, M., Konnova, A., Fransen, E., 's Jongers, B., Jairam, R. K., Van averbeke, V., Moons, P., Roelant, E., Le Blon, D., Vanden Berghe, W., Janssens, A., Lybaert, W., Croes, L., Vulsteke, C., Malhotra-Kumar, S., Goossens, H., Berneman, Z., Peeters, M., van Dam, P., Kumar-Singh, S.
10.1101/2021.10.29.21265511 — Posted: 2021-10-29
Transmission dynamics of SARS-CoV-2 in a strictly-Orthodox Jewish community in the UK
Waites, W., Pearson, C. A., Gaskell, K. M., House, T., Pellis, L., Johnson, M., Gould, V., Hunt, A., Stone, N. R., Kasstan, B., Chantler, T., Lal, S., Roberts, C. h., Goldblatt, D., CMMID COVID-19 Working Group, , Marks, M., Eggo, R. M.
10.1101/2021.10.28.21265615 — Posted: 2021-10-29
Social discrimination and stigma on the community of health professionals during the Covid-19 pandemic. An ethnographic approach
Argyriadis, A., Patelarou, A., Kitsona, V., Trivli, A., Patelarou, E., Argyriadi, A.
10.1101/2021.10.28.21265608 — Posted: 2021-10-29
A Novel Indicator for COVID-19 Pandemic Assessment and Comparison
Mukherjee, K.
10.1101/2021.10.28.21265596 — Posted: 2021-10-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).